-
HAIPAN HU
Counsel·
Shenzhen
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MS. HU’S PRACTICE INCLUDES M&A, PRIVATE EQUITY INVESTMENT, OUTBOUND INVESTMENT AND GENERAL CORPORATE.
Education
Peking University, J.M., 2016
Fudan University, B.A., 2013
Professional Qualification
Admitted to practice in the PRC
Professional Background
Ms. Hu joined Fangda in 2018. Before joining the firm, she worked at a leading domestic law firm.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented Alibaba and Ant Financial in their acquisitions, strategic investments, and cooperations with enterprises in different industries such as TMT, manufacturing and retail
- Represented TCL Technology (000100.SZ) and TCL CSOT as lead counsel in the USD 1.1 billion strategic acquisition of Samsung’s LCD business in China
- Represented TCL CSOT in its joint venture with San’an Semiconductor for Micro-LED display technology
- Represented Mindray (300760. SZ) in several major acquisitions and transactions
- Represented Nayuki, a well-known tea beverage brand in China, in its Series C financing involving investment from PAG
- Represented Hillhouse in its investments in Akrostar Technology and Jianjia Robot
- Represented CMC Capital in the equity financing of Taishan Beer, Shiyue Daotian and Forty Nine Union
- Represented an international secondary fund in the design and establishment of its PRC investment structure and vehicles
- Represented CPE in its various investments in the medical and healthcare industries as well as in the consumer goods industry
- Represented CMBI International in its investments in offshore-structured deals such as the Series C equity investment in Dmall Inc
- Represented Jinyi Capital in its strategic investments in various enterprises
- Represented Cushman & Wakefield Vanke Service in its strategic investment in and cooperation with property management service companies
- Represented China Resources Power in its acquisition of wind power projects
- Represented Kinetic (300326) in its acquisition of Elliquence, LLC, a leading US medical device manufacturer
- Represented State Power Investment Corporation in its AUD 3 billion acquisition of Pacific Hydro from IFM through an auction process
- Represented an A-share listed company in its acquisition of UK aviation manufacturing assets
- Represented Hengxin Shambala in its acquisition of shares in New Zealand-based Pukeko Pictures
- Represented a Chinese SOE consortium in its acquisition of Australian cattle station assets
- Represented IDS Medical Systems Group Limited in its joint venture with We Doctor Holdings Limited in Hong Kong
